4-[[[3-(3-fluoro-4-hydroxyphenyl)-6-methylimidazo[1,2-a]pyrazin-8-yl]amino]methyl]benzenesulfonamide
C20H18FN5O3S — CID 135931638
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[[[3-(3-fluoro-4-hydroxyphenyl)-6-methylimidazo[1,2-a]pyrazin-8-yl]amino]methyl]benzenesulfonamide
4-[[[3-(3-fluoro-4-hydroxyphenyl)-6-methylimidazo[1,2-a]pyrazin-8-yl]amino]methyl]benzenesulfonamide (PubChem CID 135931638) has the molecular formula C20H18FN5O3S and a molecular weight of 427.46 g/mol. Its IUPAC name is 4-[[[3-(3-fluoro-4-hydroxyphenyl)-6-methylimidazo[1,2-a]pyrazin-8-yl]amino]methyl]benzenesulfonamide.
Molecular Properties
| Compound Name | 4-[[[3-(3-fluoro-4-hydroxyphenyl)-6-methylimidazo[1,2-a]pyrazin-8-yl]amino]methyl]benzenesulfonamide |
|---|---|
| PubChem CID | 135931638 |
| Molecular Formula | C20H18FN5O3S |
| Molecular Weight | 427.46 g/mol |
| Exact Mass | 427.11 |
| IUPAC Name | 4-[[[3-(3-fluoro-4-hydroxyphenyl)-6-methylimidazo[1,2-a]pyrazin-8-yl]amino]methyl]benzenesulfonamide |
| SMILES | Cc1cn2c(-c3ccc(O)c(F)c3)cnc2c(NCc2ccc(S(N)(=O)=O)cc2)n1 |
| InChI | InChI=1S/C20H18FN5O3S/c1-12-11-26-17(14-4-7-18(27)16(21)8-14)10-24-20(26)19(25-12)23-9-13-2-5-15(6-3-13)30(22,28)29/h2-8,10-11,27H,9H2,1H3,(H,23,25)(H2,22,28,29) |
| InChIKey | GQVWRSBYDPACLM-UHFFFAOYSA-N |
| XLogP | 2.81 |
| TPSA | 122.61 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 427.46 |
| LogP ≤ 5 | 2.81 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135931638 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.